Fact sheet: PlrCp GblHlthcr G&IPLC

Fund information
Fund name
Polar Capital Global Healthcare Growth and Income PLC Ord 25p
Fund manager company
Polar Capital Partners Ltd
Fund type
Investment Trust
Fund managers
  • Gareth Powellsince 14/06/2010
  • Dan Mahonysince 14/06/2010
Fund objective
To generate capital growth and income by investing in a global portfolio of healthcare stocks.
Benchmark
  • MSCI AC World Healthcare (N) Index
Investment style
No data available.
Investment method
No data available.
Quick stats
1 Year return
5.3%
1 Year rank in sector
2/4
Sector
IT Biotechnology & Healthcare
Yield
2.3%
Fund size
£217m
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
151
Mid price
180
NAV
?Net asset value. The NAV per share may be higher or lower than the share price, which in turn is trading at either a discount or a premium to NAV.
190.6
Discount/Premium
?When the market price of an investment trust’s shares is less than the net asset value (NAV) per share then it is trading at a discount to NAV. A trust’s shares are on a premium when they trade at a higher price than the NAV.
-6.22
Gearing
?Investment trusts have the ability to borrow money which they invest with the aim of generating a higher return than the cost of the loan. An ungeared trust has a figure of 100. A figure of 110 would represent a trust with 10% gearing.
100
Top in this sector
Fund name1 Year
Wldwide Hlthcare Tst PLC10%
PlrCp GblHlthcr G&IPLC5.3%
Intl Biotechnology Trust4.7%
The Biotech Growth Trust PLC-3.3%
BB HlthcareTstPlcRedOrd1P-
...more in IT Biotechnology & Healthcare

Performance snapshot

Holdings snapshot

  • USA46%
    UK13.1%
    Switzerland8.6%
    International7.3%
    Japan6.4%
  • Pharmaceuticals58.8%
    Healthcare & Medical Products11.1%
    Health Care8%
    Biotechnology/Medical7.3%
    Health Care - Property5.9%
  • US Equities46%
    UK Equities13.1%
    Swiss Equities8.6%
    International Equities7.3%
    Japanese Equities6.4%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund-3.7%-4.9%5.1%5.3%38.8%93.9%
Sector3.5%1.4%12.9%6.2%66.7%206%
Rank within sector4 / 44 / 44 / 42 / 44 / 44 / 4
Quartile4th4th4th2nd4th4th
Calendar performance
 YTD - 20162015201420132012
Fund8.2%4%22.5%17.9%13.5%
Sector2.7%12.7%39.3%43.2%27.5%
Rank within sector1 / 44 / 44 / 44 / 44 / 4
Quartile1st4th4th4th4th
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
4.74
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.35
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.6
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
13.15
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
17.77
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
-0.38
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.31
Price movement
52 week high202
52 week low151.5
Current bid price179
Current offer price182.25
Current mid price180
Region
1USA46%
2UK13.1%
3Switzerland8.6%
4International7.3%
5Japan6.4%
6Money Market4.8%
7France3.9%
8Israel3.5%
9Germany3.3%
Industry sector
1Pharmaceuticals58.8%
2Healthcare & Medical Products11.1%
3Health Care8%
4Biotechnology/Medical7.3%
5Health Care - Property5.9%
6Money Market4.8%
7Hospital2.9%
8Others1.2%
Asset type
1US Equities46%
2UK Equities13.1%
3Swiss Equities8.6%
4International Equities7.3%
5Japanese Equities6.4%
6Money Market4.8%
7French Equities3.9%
8Israeli Equities3.5%
9German Equities3.3%
Individual holdings
1PFIZER INC7.4%
2MERCK & CO INC(NEW)7.2%
3JOHNSON & JOHNSON5.2%
4ASTRAZENECA PLC4.7%
5GLAXOSMITHKLINE4.6%
6ROCHE HLDG AG4.6%
7ASTELLAS PHARMA INC4.2%
8SANOFI3.9%
9TEVA PHARMACEUTICAL INDUSTRIES3.5%
Management
Fund manager group
Polar Capital
Fund manager company
Polar Capital Partners Ltd
Fund type
Investment Trust
Fund objective
To generate capital growth and income by investing in a global portfolio of healthcare stocks.
Benchmark
  • MSCI AC World Healthcare (N) Index
Investment style
No data available.
Investment method
No data available.
Fund managers
NameSinceBiography
Gareth Powell14/06/2010Gareth joined Polar Capital in 2007 to set up the healthcare team. He has over 15 years’ investment experience in the healthcare sector, with 11 years as a Portfolio Manager. He joined Framlington in 1999 becoming a Portfolio Manager on the Framlington health fund. In 2002, he helped launch and then run the Framlington biotech fund. Gareth became a CFA charterholder in 2003. Gareth studied biochemistry at Oxford from 1995 to 1999 and during that time worked at Astellas, the Sir William Dunn School of Pathology, the Wolfson Institute for Biomedical Research and the Oxford Business School.
Dan Mahony14/06/2010Daniel joined Polar Capital to set up the healthcare team in 2007. He has 23 years of industry experience, comprising more than 16 years’ investment experience in the healthcare sector, with over seven years as a Portfolio Manager and nine years as a sell-side analyst. Prior to joining Polar Capital, he was head of the European healthcare research team at Morgan Stanley, covering the European biotechnology, medical technology and healthcare services sectors. He also previously worked in New York for ING Barings Furman Selz following the US biotechnology sector. Before working in the investment field, Daniel worked as a research scientist for seven years with the majority of his time at Schering Plough Corporation in California. Daniel received his PhD from Cambridge University in 1995 and a first class honours degree in biochemistry from Oxford University in 1991.
Compliance
AIC Member
Domicile
No data available.
Fund for sale in
United Kingdom
Polar Capital Global Healthcare Growth and Income PLC Ord 25p
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price190.99
CurrencyGBX
Price updated07/12/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeNJJF
Polar Capital Global Healthcare Growth and Income PLC Sub 1P
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price43
CurrencyGBX
Price updated06/02/2014
Type-
Institutional or retail classRetail
Domicile-
Citi codeNKG8
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.